cct2

cct2

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">cct2</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>CCT2</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Chaperonin Containing TCP1 Subunit 2 (Beta)</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>12q15</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>10576</td>
</tr>
<tr>
<td class="label">OMIM ID</td>
<td>605587</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000137217</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P78371</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>535 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~57 kDa</td>
</tr>
<tr>
<td class="label">Strategy</td>
<td>Approach</td>
</tr>
<tr>
<td class="label">CCT modulators</td>
<td>Enhance CCT function</td>
</tr>
<tr>
<td class="label">Substrate stabilizers</td>
<td>Stabilize CCT substrates</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>Increase CCT expression</td>
</tr>
<tr>
<td class="label">Combination approaches</td>
<td>With other chaperones</td>
</tr>
<tr>
<td class="label">Interactor</td>
<td>Function</td>
</tr>
<tr>
<td class="label">Other CCT subunits</td>
<td>Complex formation</td>
</tr>
<tr>
<td class="label">Actin</td>
<td>Substrate</td>
</tr>
<tr>
<td

cct2

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">cct2</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>CCT2</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Chaperonin Containing TCP1 Subunit 2 (Beta)</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>12q15</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>10576</td>
</tr>
<tr>
<td class="label">OMIM ID</td>
<td>605587</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000137217</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P78371</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>535 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~57 kDa</td>
</tr>
<tr>
<td class="label">Strategy</td>
<td>Approach</td>
</tr>
<tr>
<td class="label">CCT modulators</td>
<td>Enhance CCT function</td>
</tr>
<tr>
<td class="label">Substrate stabilizers</td>
<td>Stabilize CCT substrates</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>Increase CCT expression</td>
</tr>
<tr>
<td class="label">Combination approaches</td>
<td>With other chaperones</td>
</tr>
<tr>
<td class="label">Interactor</td>
<td>Function</td>
</tr>
<tr>
<td class="label">Other CCT subunits</td>
<td>Complex formation</td>
</tr>
<tr>
<td class="label">Actin</td>
<td>Substrate</td>
</tr>
<tr>
<td class="label">Tubulin</td>
<td>Substrate</td>
</tr>
<tr>
<td class="label">Hsp70</td>
<td>Co-chaperone cooperation</td>
</tr>
<tr>
<td class="label">Hsp90</td>
<td>Proteostasis network</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/huntington" style="color:#ef9a9a">Huntington</a>, <a href="/wiki/inflammation" style="color:#ef9a9a">Inflammation</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">68 edges</a></td>
</tr>
</table>

The CCT2 gene encodes the beta subunit of the Chaperonin Containing TCP1 (CCT) complex, also known as the TCP-1 ring complex (TRiC). CCT2 is one of eight distinct subunits (CCT1-8) that comprise this hetero-oligomeric chaperone system, which is essential for the proper folding of the majority of eukaryotic cytoskeletal proteins, particularly actin and tubulin[@yaffe2002].

The CCT complex represents a critical component of the cellular protein quality control machinery. Unlike other chaperones, CCT has evolved to handle specific, essential substrates including actin, tubulin, and numerous other proteins involved in key cellular processes. In neurons, where cytoskeletal dynamics are fundamental for synaptic function, axonal transport, and overall cellular integrity, CCT-mediated protein folding is particularly crucial[@willison1999].

Gene Structure and Chromosomal Location

The CCT2 gene consists of 13 exons and encodes a protein with a molecular weight of approximately 57 kDa. The protein localizes to the cytosol where it functions as part of the larger CCT complex.

Protein Structure and Function

CCT Complex Architecture

The CCT complex is a barrel-shaped hetero-oligomeric chaperone consisting of eight distinct subunits arranged in two stacked rings[@lopez1997]:

• CCT1 (α), CCT2 (β), CCT3 (γ), CCT4 (δ), CCT5 (ε): Form one ring
• CCT6 (ζ), CCT7 (η), CCT8 (θ): Form the opposing ring
• Each subunit is approximately 50-60 kDa
• Together they form a ~1 MDa complex

CCT2 Structure

CCT2 features the characteristic chaperonin fold:

• Equatorial domain: ATP-binding site, interacts with other subunits
• Apical domain: Substrate-binding site, undergoes conformational changes
• Intermediate domain: Connects equatorial and apical domains
• ATP-binding pocket: Essential for chaperone function

Chaperone Function

CCT2, as part of the CCT complex, mediates protein folding through[@kubota2005]:

Substrate Specificity

The CCT complex has broad but specific substrate recognition[@frydman2001]:

• Actin: Essential for actin filament formation
• Tubulin: Required for microtubule polymerization
• Vimentin: Intermediate filament protein
• Cyclin E: Cell cycle regulatory protein
• G-protein subunits: Signaling molecules

Role in Neurodegenerative Diseases

Alzheimer's Disease

CCT dysfunction contributes to AD pathogenesis through multiple mechanisms[@grantham2020]:

Tau pathology: CCT is involved in tau folding and processing:

• CCT assists in proper folding of tau protein
• Dysfunction may contribute to tau misfolding and aggregation
• Impaired CCT function affects tau phosphorylation machinery

• Aβ can impair cytosolic protein folding capacity
• CCT activity declines in AD brains
• Contributes to overall proteostasis collapse

• Actin dynamics at synapses require CCT function
• Tubulin for axonal transport depends on CCT
• Synaptic dysfunction ensues when CCT is impaired

Parkinson's Disease

CCT plays significant roles in PD pathogenesis[@brasseur2020]:

Alpha-synuclein interactions:

• CCT can modulate α-synuclein aggregation
• Mutations affecting CCT function may influence pathology
• Therapeutic targeting of CCT is under investigation

• CCT assists in LRRK2 folding
• Mutant LRRK2 may have increased CCT dependence
• CCT modulators could affect LRRK2 toxicity

• High metabolic demands require efficient protein folding
• CCT dysfunction contributes to neuronal death
• Mitochondrial connections to CCT function

Amyotrophic Lateral Sclerosis

CCT involvement in ALS[@gottstein2022]:

Protein aggregation:

• TDP-43 and FUS require CCT for proper folding
• CCT dysfunction contributes to aggregation
• Therapeutic targeting being explored

• High protein turnover in motor neurons
• CCT capacity becomes limiting
• Contributes to degeneration

Huntington's Disease

CCT affects mutant huntingtin:

• Mutant HTT may overwhelm CCT capacity
• CCT helps fold polyglutamine-containing proteins
• Impaired CCT function in HD models

CCT in Normal Brain Function

Synaptic Function

CCT is essential for synaptic processes[@spong2019]:

• Actin cytoskeleton: Required for dendritic spine formation
• Axonal transport: Tubulin folding essential for transport
• Synaptic vesicle cycling: Actin-dependent processes
• Synaptic plasticity: Requires dynamic cytoskeleton

Neuronal Morphology

CCT supports neuronal structure:

• Axon guidance: Cytoskeletal dynamics in development
• Dendrite branching: Requires proper protein folding
• Myelination: Oligodendrocyte function depends on CCT

Cell Cycle and Division

While neurons are post-miotic:

• CCT function in glial cell proliferation
• Support for neural precursor cells
• Developmental processes require CCT

Therapeutic Implications

Targeting CCT in Neurodegeneration

Several therapeutic strategies are being explored:

Challenges

• Complex regulation: Multiple subunits, coordinated function
• Essential function: Complete loss is lethal
• Specificity: Broad substrates, potential off-target effects

Expression Pattern

CCT2 is:

• Ubiquitously expressed: Across all tissues
• High in brain: Particularly in neurons
• Cytosolic localization: As part of the CCT complex
• Developmental regulation: Expressed throughout development

• High expression in [neurons](/entities/neurons)
• Present in [astrocytes](/entities/astrocytes)
• Enriched in synaptic regions

Interaction Network

CCT2 interacts with:

Research Models

Cell Culture

• Primary neurons: Primary cortical neurons
• iPSC models: Patient-derived neurons with CCT variants
• Knockdown studies: siRNA approaches

Animal Models

• Cct2 knockout: Embryonic lethal, essential gene
• Conditional knockouts: Reveal tissue-specific functions
• Transgenic models: Overexpression studies

Summary

CCT2 encodes the beta subunit of the CCT complex, a critical cytosolic chaperone essential for folding of actin, tubulin, and numerous other substrates. CCT dysfunction contributes to neurodegenerative diseases including AD, PD, and ALS through effects on cytoskeletal integrity, protein quality control, and synaptic function. Therapeutic targeting of CCT offers promise for neuroprotection, though challenges remain in achieving specific modulation[@stadelmann2010][@hogue2002][@valpuesta2002].

CCT2 in Cellular Physiology

Protein Quality Control Network

CCT2 operates within the broader cellular protein quality control network[@mohan2019]:

• Cooperation with Hsp70: Hsp70 delivers substrates to CCT
• Proteasome collaboration: Degradation of misfolded proteins
• Autophagy connections: Aggregate clearance pathways
• Stress response integration: Links to heat shock response

ATP-Dependent Chaperone Cycle

The CCT chaperone cycle is highly regulated:

Substrate Recognition Mechanisms

CCT has developed sophisticated substrate recognition:

• Hydrophobic patches: Recognizes exposed hydrophobic residues
• Timing: Co-translational folding assistance
• Co-chaperone delivery: Hsp70/Hsp40 deliver substrates
• Post-translational modification: Phosphorylation affects binding

CCT2 in Aging and Neurodegeneration

Age-Related Changes

CCT function declines with age:

• Reduced expression: CCT subunit levels decrease
• Post-translational modifications: Oxidation affects function
• ATP depletion: Energy limitation impairs cycling
• Aggregate overload: Capacity becomes exceeded

Implications for Neurodegeneration

Age-related CCT decline contributes to:

• Proteostasis collapse: Impaired protein folding
• Cytoskeletal disruption: Actin/tubulin dysfunction
• Synaptic failure: Loss of synaptic proteins
• Axonal degeneration: Transport impairments

CCT2 as Therapeutic Target

Small Molecule Modulators

Several approaches are being developed:

• ATPase modulators: Enhance CCT cycling
• Substrate stabilizers: Protect substrates during folding
• Co-chaperone enhancers: Improve substrate delivery

Gene Therapy Approaches

• Viral delivery: AAV-mediated CCT2 expression
• CRISPR activation: Increase endogenous expression
• Combination strategies: With other chaperones

Research Tools and Models

Model Systems

• Yeast models: Genetic tractability for mechanism studies
• Drosophila: In vivo models of neurodegeneration
• Mouse models: Transgenic and knockout approaches
• iPSC neurons: Patient-derived disease models

Biochemical Tools

• Purified CCT: In vitro folding assays
• Crosslinking: Substrate interaction studies
• Cryo-EM: Structural analysis of CCT-substrate complexes

Clinical Relevance

Disease Biomarkers

CCT levels may serve as biomarkers:

• Blood CCT: Detectable in plasma
• CSF CCT: Cerebrospinal fluid levels
• Exosomal CCT: Neuron-derived exosomes

Genetic Associations

CCT2 variants may modify disease risk:

• Polymorphisms: May affect chaperone function
• Expression changes: Altered levels in disease
• Therapeutic implications: Target for modulation

Pathway Diagram

The following diagram shows the key molecular relationships involving cct2 discovered through SciDEX knowledge graph analysis:

Pathway Diagram

The following diagram shows the key molecular relationships involving cct2 discovered through SciDEX knowledge graph analysis: